IART

Integra Lifesciences Holdings Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↓ 0/10
  • Momentum↓ 3/10
Integra Lifesciences Holdings sales and earnings growth
IART Growth
Low
  • Revenue Y/Y↓ 4.99%
  • EPS Y/Y↓ -7975.00%
  • FCF Y/Y↓ -111.87%
Integra Lifesciences Holdings gross and profit margin trends
IART Profitability
Fair
  • Gross margin ↑ 52.30%
  • EPS margin↓ -30.10%
  • ROIC↓ -16.60%
Integra Lifesciences Holdings net debt vs free cash flow
IART Risk
Good
  • Debt / Equity↓ 1.9
  • Debt / FCF↑ 392.9
  • Interest coverage↓ -5.7

Integra Lifesciences Holdings stock volatility is in-line with the overall market. We give it a Good risk rating.

More Medical Devices stocks ↗